Literature DB >> 29127059

Hypertension and cardiovascular risk: General aspects.

Sverre E Kjeldsen1.   

Abstract

Hypertension is the strongest or one of the strongest risk factors for almost all different cardiovascular diseases acquired during life, including coronary disease, left ventricular hypertrophy and valvular heart diseases, cardiac arrhythmias including atrial fibrillation, cerebral stroke and renal failure. The continuous relationship between blood pressure and cardiovascular and renal events makes the distinction between high normal blood pressure and hypertension based on arbitrary cut-off values for blood pressures. Overall the prevalence of hypertension in different European countries appears to be around 30-45% of the general population, with a steep increase with ageing. The prevention of cardiovascular disease and treatment recommendations should be related to quantification of total cardiovascular risk which could be estimated from several different models. However the impact of age on risk is so strong that young adults (particularly women) are unlikely to reach high-risk levels even when they have more than one major risk factor and a clear increase in relative risk. Therefore age-adjusted models, models assessing relative risks compared to others of same age and models including thorough assessments of target organ damage and ambulatory 24h blood pressure are needed together with national models because of the large variations between countries.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood pressure; Cardiovascular risk; Cerebral stroke; Hypertension; Renal disease; Target organ damage

Mesh:

Year:  2017        PMID: 29127059     DOI: 10.1016/j.phrs.2017.11.003

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  88 in total

1.  The burden of heart failure in the general population: a clearer and more concerning picture.

Authors:  Thomas G von Lueder; Stefan Agewall
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Association of sleep trajectory in adulthood with risk of hypertension and its related risk factors: the China Health and Nutrition Survey.

Authors:  Yuexuan Wang; Wanying Hou; Sultan Mehmood Siddiqi; Changhao Sun; Tianshu Han; Jianjun Yang
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

3.  Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

Authors:  Daniela Medina; Amy C Arnold
Journal:  Am J Hypertens       Date:  2019-11-15       Impact factor: 2.689

4.  Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study.

Authors:  Yi-Lung Chen; Chun-Hung Pan; Chi-Kang Chang; Pao-Huan Chen; Hu-Ming Chang; Ming-Hong Tai; Sheng-Shiang Su; Shang-Ying Tsai; Chiao-Chicy Chen; Chian-Jue Kuo
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

5.  Ph- myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide.

Authors:  Milan Košťál; Jiří Schwarz; Petra Ovesná; Miroslav Penka; Petr Dulíček
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

Review 6.  Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?

Authors:  Lia E Taylor; Lindsey A Ramirez; Jacqueline B Musall; Jennifer C Sullivan
Journal:  Br J Pharmacol       Date:  2019-08-19       Impact factor: 8.739

Review 7.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

8.  Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Christina D Filippou; Costas P Tsioufis; Costas G Thomopoulos; Costas C Mihas; Kyriakos S Dimitriadis; Lida I Sotiropoulou; Christina A Chrysochoou; Petros I Nihoyannopoulos; Dimitrios M Tousoulis
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

9.  Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2020-02-20       Impact factor: 9.621

10.  ACE (Angiotensin-Converting Enzyme) Inhibition Reverses Vasoconstriction and Impaired Dilation of Pial Collaterals in Chronic Hypertension.

Authors:  Zhaojin Li; Devon P Lindner; Nicole M Bishop; Marilyn J Cipolla
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.